Jubak Picks Portfolio Performance 1997-2017
Buy and hold? Not really.
Not by a long shot.
So what is the stock-picking style of The Jubak Picks portfolio?
Click to expand...
I try to go with the market’s momentum when the trend is strong and the risk isn’t too high, and I go against the herd when the bulls have turned piggy and the bears have lost all perspective. What are the results of this moderately active — the holding period is 12 to 18 months — all-stock portfolio since inception in May 1997? A total return of 483% as of December 31, 2017. That compares to a total return on the S&P 500 stock index of 125% during the same period.
Jubak Top 50 Portfolio Performance for 2017
Click to expand...
In The Jubak Picks I identified ten trends that were strong enough, global enough, and long-lasting enough to give anyone who invested in them a good chance of beating the stock market averages.
To mark the publication of my new book on volatility, Juggling with Knives, and to bring the existing long-term picks portfolio into line with what I learned in writing that book and my best new ideas on how to invest for the long-term in a period of high volatility, I’m completely overhauling the existing Top 50 Picks portfolio.
You can buy Juggling with Knives at bit.ly/jugglingwithknives
Dividend Income Portfolio Performance for 2017
Every income investor needs a healthy dose of dividend stocks.
Why not just concentrate on bonds or CDs?
Click to expand...
Because all the different income-producing assets available to income investors have characteristics that make them suited to one market and not another. You need all of these types of assets if you’re going to generate maximum income with minimum risk as the market twists and turns.
For example: bonds are great when interest rates are falling. Buy early in that kind of market and you can just sit back and collect that initial high yield as well as the capital gains that are generated as the bonds appreciate in price with each drop in interest rates.
CDs, on the other hand, are a great way to lock in a yield with almost absolute safety when you’d like to avoid the risk of having to reinvest in an uncertain market or when interest rates are crashing.
Dividend stocks have one very special characteristic that sets them apart from bonds and CDs: companies raise dividends over time. Some companies raise them significantly from one quarter or year to the next. That makes a dividend-paying stock one of the best sources of income when interest rates start to rise.
Bonds will get killed in that environment because bond prices will fall so that yields on existing bonds keep pace with rising interest rates.
But because interest rates usually go up during periods when the economy is cooking, there’s a very good chance that the company you own will be seeing rising profits. And that it will raise its dividend payout to share some of that with shareholders.
With a dividend stock you’ve got a chance that the yield you’re collecting will keep up with rising market interest rates.
But wouldn’t ya know it?
Just when dividend investing is getting to be more important—becoming in my opinion the key stock market strategy for the current market environment—it’s also getting to be more difficult to execute with shifting tax rates and special dividends distorting the reported yield on many stocks.
I think there’s really only one real choice—investors have to pull up their socks and work even harder at their dividend investing strategy. That’s why I revamped the format of the Dividend Income portfolio that I’ve been running since October 2009. The changes aren’t to the basic strategy. That’s worked well, I think, and I’ll give you some numbers later on so you can judge for yourself. No, the changes are designed to do two things: First, to let you and me track the performance of the portfolio more comprehensively and more easily compare it to the performance turned in by other strategies, and second, to generate a bigger and more frequent roster of dividend picks so that readers, especially readers who suddenly have a need to put more money to work in a dividend strategy, have more dividend choices to work with.
Why is dividend investing so important in this environment? I’ve laid out the reasons elsewhere but let me recapitulate here. Volatility will create repeated opportunities to capture yields of 5%–the “new normal” and “paranormal” target rate of return–or more as stock prices fall in the latest panic. By using that 5% dividend yield as a target for buys (and sells) dividend investors will avoid the worst of buying high (yields won’t justify the buy) and selling low (yields will argue that this is a time to buy.) And unlike bond payouts, which are fixed by coupon, stock dividends can rise with time, giving investors some protection against inflation.
The challenge in dividend investing during this period is using dividend yield as a guide to buying and selling without becoming totally and exclusively focused on yield. What continues to matter most is total return. A 5% yield can get wiped out very easily by a relatively small drop in share price.
Going forward, I will continue to report on the cash thrown off by the portfolio—since I recognize that many investors are looking for ways to increase their current cash incomes. But I’m also going to report the total return on the portfolio—so you can compare this performance to other alternatives—and I’m going to assume that an investor will reinvest the cash from these dividend stocks back into other dividend stocks. That will give the portfolio—and investors who follow it—the advantage of compounding over time, one of the biggest strengths in any dividend income strategy.
What are some of the numbers on this portfolio? $29,477 in dividends received from October 2009 through December 31, 2013. On the original $100,000 investment in October 2009 that comes to a 29.5% payout on that initial investment over a period of 39 months. That’s a compound annual growth rate of 8.27%.
And since we care about total return, how about capital gains or losses from the portfolio? The total equity price value of the portfolio came to $119,958 on December 31, 2012. That’s a gain of $19,958 over 39 months on that initial $100,000 investment or a compound annual growth rate of 5.76%.
The total return on the portfolio for that period comes to $49,435 or a compound annual growth rate of 13.2%.
How does that compare to the total return on the Standard & Poor’s 500 Stock Index for that 39-month period? In that period $100,000 invested in the S&P 500 would have grown to $141,468 with price appreciation and dividends included.) That’s a total compounded annual rate of return of 11.26%.
That’s an annual 2 percentage point advantage to my Dividend Income portfolio. That’s significant, I’d argue, in the context of a low risk strategy.
Portfolio Related Posts
I think today is just a pause in the China-coronavirus selling; I’m selling China Southern Airlines out of my 50 Stocks Portfolio today on the bounce.
Airline stocks have been among the hardest hit equities in the coronavirus selling. As the biggest airline in China and indeed in all of Asia China Southern Airlines (ZNH) has sold off especially quickly. The New York traded ADRs sold at $35.41 on January 14 and were at $28.00 at 3:20 p.m. New York time today, January 28. That’s drop of 35% in two weeks (even though the ADRs are up 1.89% today.) In my thinking we’ve still got a way to go before markets can breathe a true sigh of relief and put coronavirus fears behind them. And move onto worrying about other things like economic growth rates in China, rising debt levels, and earnings growth for U.S. stocks in the first and second quarters of 2020. Normally I wouldn’t sell a long-term pick out of my 50 Stocks Portfolio on a short-term event like this. But…
Yesterday when the market was a sea of red, shares of AbbVie (ABBV) were a small beacon of green. Today when, as of 3:40 p.m. most of the market is green, AbbVie is a small spark of red. What’s up?
There’s no official announcement from Apple yet, but iPhone assemblers including Hon Hai Precision Industry, Pegatron, and Wistron, are planning to begin producing a new lower-cost iPhone in February. Apple is expected to official announce the new phone in March. According to sources in the Apple-supply chain the phone will look similar to the iPhone 8 with a 4.7-inch screen, a Touch ID built in the home button, and will run on the same chip as Apple’s current iPhone 11. Since there is no official announcement yet, there’s no official price either.
In my most recent Special Report: When to sell: What to sell on my JubakAM.Com subscription site I recommended that any current rebalancing build up some cash. To implement that cash-building strategy, when you sell to rebalance a portfolio for 2020, buy fewer stocks than you sell so that the result is more cash on the sidelines. For example, in the rebalancing of my long-term 50 Stocks portfolio I’ve sold enough stocks so that this portfolio dropped to 38 stocks instead of the 50 in the headline. Today, Tuesday, January 21, I’ll be making my initial buys for 2020 to complete the rebalancing of this portfolio. But I expect to buy just four stocks, which would leave me with 42 stocks instead of 50 and about 16% in cash
Last night, I made Wesco International (WCC) my #11 Pick for my Special Report: 12 Bargain Stock Picks NOW on my Jubak.com subscription site. Today I’m adding Wesco International to my Jubak Picks Portfolio.
Yesterday, the day of the announcement of the Part 1 trade deal between the United States and China, shares of Via (V) climbed 1.91%. MasterCard (MA) gained 1.16%. American Express rose 0.79%. On a day when the Standard & Poor’s 500 fell 0.15% and the Dow Jones Industrial Average gained just 0.11%. Today the overall market was much stronger with the S&P 500 gaining 0.84% at the close and the Dow Industrials ahead 0.92%, but Visa (up 0.58%), MasterCard (up 1.93%) and American Express (up 0.56%) added to the previous day’s gains rather than giving ground. What’s up with these stocks?
I understand why the U.S. Food & Drug Administration has moved so slowly on a decision on Nektar Therapeutic’s (NKTR) new non-addictive opioid NKTR-181. The last thing the FDA wants to do in the midst of epidemic of opioid addiction is to approve a drug that might be one part of a solution to the problem only to have it turn out to have harmful side effects or ineffective or, maybe worst of all, itself addictive. But the delay–I remember looking for an advisory committee vote last summer has been torture for any one who holds the stock.
Apple’s iPhone shipments in China grew 18.7% year over year in December to roughly 3.18 million units, according to Bloomberg. (Bloomberg’s calculations are based on data from the China Academy of Information and Communication Technology, a government think tank. The growth rate is especially impressive given a drop in overall smartphone shipments in China of 13.7% ear over year in December.